Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2026-01-01 @ 2:50 AM
Study NCT ID:
NCT00837551
Status:
COMPLETED
Last Update Posted:
2009-02-05
First Post:
2009-02-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase IIa Study of WBI-1001 Cream for Atopic Dermatitis
Sponsor:
Welichem Biotech Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
WBI-1001-201: Control # 119727
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Robert Bissonnette
Old Organization:
Innovaderm Reseaerch Inc.